Literature DB >> 11450847

Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for nonketotic hyperglycinemia.

S Kure1, K Kojima, T Kudo, K Kanno, Y Aoki, Y Suzuki, T Shinka, Y Sakata, K Narisawa, Y Matsubara.   

Abstract

Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism caused by deficiency in the glycine cleavage system (GCS); this system consists of four individual constituents, P-, T-, H-, and L-proteins. Several mutations have been identified in P- and T-protein genes, but not in the H-protein gene (GCSH), despite the presence of case reports of H-protein deficiency. To facilitate the mutational and functional analyses of GCSH, we isolated and characterized a human p1-derived artificial chromosome (PAC) clone encoding GCSH. GCSH spanned 13.5kb and consisted of five exons. Using the PAC clone as a probe, we mapped GCSH to chromosome 16q24 by fluorescence in situ hybridization. The transcription initiation site was determined by the oligonucleotide-cap method, and potential binding sites for several transcriptional factors were found in the 5' upstream region. Direct sequencing analysis revealed five single-nucleotide polymorphisms. The expression profiles of P-, T-, and H-protein mRNAs were studied by dot-blot analysis, using total RNA from various human tissues. GCSH was expressed in all 29 tissues examined, while T-protein mRNA was detected in 27 of the 29 tissues. In contrast, the P-protein gene was expressed in a limited number of tissues, such as liver, kidney, brain, pituitary gland, and thyroid gland, suggesting distinct transcriptional regulation of each GCS constituent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450847     DOI: 10.1007/s100380170057

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

Review 1.  One-Carbon Metabolism in Health and Disease.

Authors:  Gregory S Ducker; Joshua D Rabinowitz
Journal:  Cell Metab       Date:  2016-09-15       Impact factor: 27.287

2.  The Mutation Analysis of the AMT Gene in a Chinese Family With Nonketotic Hyperglycinemia.

Authors:  Bing-Bo Zhou; Ling Hui; Qing-Hua Zhang; Xue Chen; Chuan Zhang; Lei Zheng; Xuan Feng; Yu-Pei Wang; Zhong-Jun Ding; Rui-Rong Chen; Pan-Pan Ma; Fu-Rong Liu; Sheng-Ju Hao
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

3.  Two Novel GLDC Mutations in a Neonate with Nonketotic Hyperglycinemia.

Authors:  Sarah L Nickerson; Shanti Balasubramaniam; Philippa A Dryland; Jennifer M Love; Maina P Kava; Donald R Love; Debra O Prosser
Journal:  J Pediatr Genet       Date:  2016-06-15

4.  Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia.

Authors:  Junko Kanno; Tim Hutchin; Fumiaki Kamada; Ayumi Narisawa; Yoko Aoki; Yoichi Matsubara; Shigeo Kure
Journal:  J Med Genet       Date:  2007-03       Impact factor: 6.318

Review 5.  The glycine deportation system and its pharmacological consequences.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Pharmacol Ther       Date:  2012-05-11       Impact factor: 12.310

6.  Metabolite-based mutualism enhances hydrogen production in a two-species microbial consortium.

Authors:  Shaojie Wang; Hongzhi Tang; Fei Peng; Xijia Yu; Haijia Su; Ping Xu; Tianwei Tan
Journal:  Commun Biol       Date:  2019-02-28

7.  Glycine cleavage system determines the fate of pluripotent stem cells via the regulation of senescence and epigenetic modifications.

Authors:  Shengya Tian; Junru Feng; Yang Cao; Shengqi Shen; Yongping Cai; Dongdong Yang; Ronghui Yan; Lihua Wang; Huafeng Zhang; Xiuying Zhong; Ping Gao
Journal:  Life Sci Alliance       Date:  2019-09-27

8.  GCSH antisense regulation determines breast cancer cells' viability.

Authors:  Anna Adamus; Petra Müller; Bente Nissen; Annika Kasten; Stefan Timm; Hermann Bauwe; Guido Seitz; Nadja Engel
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

9.  Nonketotic hyperglycinemia in Suleimaniah Children's Hospital, Riyadh, Saudi Arabia.

Authors:  Devabrata Roy; Ali Al-Asmari; Yousef K Ghazal; Saleh Al-Oqiel
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.